Microbix Biosystems Inc.
MBX.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -321.07% | -163.20% | -106.34% | -62.36% | -49.16% |
| Total Depreciation and Amortization | 11.32% | 15.13% | 10.01% | 19.01% | 29.76% |
| Total Amortization of Deferred Charges | -50.73% | -75.22% | -1.64% | -1.64% | -1.64% |
| Total Other Non-Cash Items | 17.05% | 12.49% | 151.90% | 148.12% | 149.35% |
| Change in Net Operating Assets | -184.28% | 58.30% | 22.44% | 60.63% | 64.54% |
| Cash from Operations | -190.86% | -102.80% | -73.42% | 34.14% | 294.05% |
| Capital Expenditure | 58.70% | 52.74% | 44.35% | -36.25% | -93.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | 64.07% | 59.41% | 52.68% | -62.68% | -122.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -170.63% | -171.44% | -172.32% | -470.13% | -77.41% |
| Issuance of Common Stock | 517.23% | 674.16% | 690.06% | 666.88% | 353.37% |
| Repurchase of Common Stock | -0.65% | -87.03% | -130.04% | -116.06% | -71.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 117.96% | 100.52% | 51.02% | 13.75% | -552.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,585.54% | -165.56% | -19.61% | 38.13% | -24.51% |